• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植患者中的HLA - A28与类固醇诱导的糖尿病

HLA-A28 and steroid-induced diabetes in renal transplant patients.

作者信息

David D S, Cheigh J S, Braun D W, Fotino M, Stenzel K H, Rubin A L

出版信息

JAMA. 1980 Feb 8;243(6):532-3.

PMID:6985991
Abstract

Between July 1971 and March 1977, steroid-induced diabetes (SD) developed postoperatively in 31 (10.8%) of 286 nondiabetic adult kidney transplant recipients who were observed for a total of 410 patient transplant years. There was a highly significant association between HLA-A28 and SD. There was no significant association between SD and BB or Bw 15. Age was also associated with SD. However, A28 was associated with SD even when corrected for age. A28 occurred more frequently in blacks than whites, 25.4% and 6.3%, respectively, and accounted for the higher incidence of SD in black adults. There were no significant associations between SD and patients' sex, donor source, number of short-term rejection treatments, or maintenance dose of corticosteroids. Steroid-induced diabetes had no adverse effects on graft or patient survival.

摘要

1971年7月至1977年3月期间,在286名非糖尿病成年肾移植受者中,有31名(10.8%)在术后出现了类固醇诱导的糖尿病(SD),这些受者的观察期总计为410个患者移植年。HLA - A28与SD之间存在高度显著的关联。SD与BB或Bw15之间无显著关联。年龄也与SD有关。然而,即使校正年龄后,A28仍与SD相关。A28在黑人中的出现频率高于白人,分别为25.4%和6.3%,这也解释了成年黑人中SD发病率较高的原因。SD与患者的性别、供体来源、短期排斥治疗次数或皮质类固醇维持剂量之间均无显著关联。类固醇诱导的糖尿病对移植物或患者存活没有不良影响。

相似文献

1
HLA-A28 and steroid-induced diabetes in renal transplant patients.肾移植患者中的HLA - A28与类固醇诱导的糖尿病
JAMA. 1980 Feb 8;243(6):532-3.
2
Racial differences in the incidence of steroid diabetes in renal transplant patients.肾移植患者中类固醇糖尿病发病率的种族差异。
Henry Ford Hosp Med J. 1982;30(1):14-16.
3
Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors.尸体肾移植受者存活情况的种族差异。HLA配型和社会经济因素的主导作用。
N Engl J Med. 1992 Sep 17;327(12):840-5. doi: 10.1056/NEJM199209173271203.
4
The UNOS Scientific Renal Transplant Registry.美国器官共享联合网络科学肾脏移植登记处。
Clin Transpl. 1996:1-14.
5
Racial variation in human leukocyte antigen frequency in insulin-dependent diabetic nephropathy. The South-Eastern Organ Procurement Foundation.胰岛素依赖型糖尿病肾病中人类白细胞抗原频率的种族差异。东南器官采购基金会。
J Am Soc Nephrol. 1993 Feb;3(8):1467-73. doi: 10.1681/ASN.V381467.
6
Conversion From Steroid to Everolimus in Maintenance Kidney Transplant Recipients With Posttransplant Diabetes Mellitus.肾移植术后糖尿病维持期受者从类固醇转换为依维莫司的研究
Exp Clin Transplant. 2019 Feb;17(1):47-51. doi: 10.6002/ect.2017.0178. Epub 2018 Jun 18.
7
Impact of race on renal transplant outcome.种族对肾移植结果的影响。
Transplantation. 1990 Jan;49(1):63-7. doi: 10.1097/00007890-199001000-00014.
8
Steroid avoidance reduce the cost of morbidities after live-donor renal allotransplants: a prospective, randomized, controlled study.避免使用类固醇可降低活体供肾肾移植术后并发症的成本:一项前瞻性、随机、对照研究。
Exp Clin Transplant. 2011 Apr;9(2):121-7.
9
Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.肾移植受者的早期类固醇撤药疗法:一种基于无类固醇西罗莫司和骁悉的钙调神经磷酸酶抑制剂最小化方案。
Clin Transplant. 2007 Jan-Feb;21(1):101-9. doi: 10.1111/j.1399-0012.2006.00613.x.
10
Donor race does not affect cadaver kidney transplant survival--a single center experience.供体种族不影响尸体肾移植的存活率——单中心经验
Transplantation. 1995 Dec 27;60(12):1401-6. doi: 10.1097/00007890-199560120-00005.

引用本文的文献

1
HLA Alleles Cw12 and DQ4 in Kidney Transplant Recipients Are Independent Risk Factors for the Development of Posttransplantation Diabetes.肾移植受者中的人类白细胞抗原Cw12和DQ4等位基因是移植后糖尿病发生的独立危险因素。
Transplant Direct. 2021 Jul 23;7(8):e737. doi: 10.1097/TXD.0000000000001188. eCollection 2021 Aug.
2
New-Onset Diabetes Mellitus (NODM) After Liver Transplantation (LT): The Ultimate Non-diabetogenic Immunosuppressive Therapy.肝移植后新发糖尿病(NODM):终极非致糖尿病性免疫抑制疗法
Cureus. 2022 Mar 29;14(3):e23635. doi: 10.7759/cureus.23635. eCollection 2022 Mar.
3
Early steroid withdrawal regimen prevents new-onset diabetes mellitus in old-age recipients after living donor liver transplantation.
早期类固醇撤药方案可预防老年活体肝移植受者发生新发糖尿病。
World J Surg. 2012 Oct;36(10):2443-8. doi: 10.1007/s00268-012-1661-6.
4
Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation.初步研究:肾移植后传统及遗传风险因素与新发糖尿病的关联
Transplant Proc. 2009 Dec;41(10):4172-7. doi: 10.1016/j.transproceed.2009.08.063.
5
Sirolimus is associated with new-onset diabetes in kidney transplant recipients.西罗莫司与肾移植受者新发糖尿病有关。
J Am Soc Nephrol. 2008 Jul;19(7):1411-8. doi: 10.1681/ASN.2007111202. Epub 2008 Apr 2.
6
Post-transplant diabetes mellitus: risk reduction strategies in the elderly.移植后糖尿病:老年人的风险降低策略
Drugs Aging. 2006;23(10):781-93. doi: 10.2165/00002512-200623100-00002.
7
Post-transplant diabetes mellitus. The role of immunosuppression.移植后糖尿病。免疫抑制的作用。
Drug Saf. 1997 Apr;16(4):242-57. doi: 10.2165/00002018-199716040-00002.
8
In vivo effect of FK506 on human pancreatic islets.FK506对人胰岛的体内作用。
Transplantation. 1991 Sep;52(3):519-22. doi: 10.1097/00007890-199109000-00026.
9
Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients.肝移植受者接受FK 506挽救治疗后的血糖水平和胰岛素需求情况。
Transplant Proc. 1991 Feb;23(1 Pt 2):949-53.
10
Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice.FK 506对糖尿病裸鼠肾被膜下移植后人胰岛的影响。
Transplant Proc. 1992 Jun;24(3):1042.